| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | GSK620 is a potent and orally active pan-BD2 inhibitor with excellent broad selectivity, developability, and in vivo oral pharmacokinetics. Highly selective for the BET-BD2 family of proteins, GSK620 exhibits over 200-fold selectivity over all other bromodomains. In human whole blood, GSK620 demonstrates an anti-inflammatory phenotype [1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 3.07mL 0.61mL 0.31mL | 15.37mL 3.07mL 1.54mL | 30.74mL 6.15mL 3.07mL | 
| 参考文献 | 
|---|